The median time since prostate cancer diagnosis was 1.0 month (IQR: 1.0 to 2.0 months), with median prostate-specific antigen (PSA) levels of 7.0 ng.ml−1 (IQR: 3.9 to 9.5 ng.ml−1) and Gleason Score of 7.0 (IQR: 7.0 to 7.0). This evidence concerns the gene KLK3 and prostate cancer.